Structures by: Qi B.
Total: 18
C40H54N14O41W12Zn3
C40H54N14O41W12Zn3
Nature Communications (2015) 6, 10007
a=15.1029(8)Å b=13.2535(6)Å c=18.0330(9)Å
α=90.00° β=94.440(3)° γ=90.00°
C40H54N14O41W12Zn3
C40H54N14O41W12Zn3
Nature Communications (2015) 6, 10007
a=15.0880(4)Å b=13.2353(3)Å c=18.0221(5)Å
α=90.00° β=94.414(2)° γ=90.00°
C40H60Cu3KN8O54RuSiW11
C40H60Cu3KN8O54RuSiW11
Chem. Sci. (2015) 6, 2 1035
a=24.415(3)Å b=24.415(3)Å c=15.337(4)Å
α=90.00° β=90.00° γ=90.00°
C40H58Cu2KN8O52RuSiW11
C40H58Cu2KN8O52RuSiW11
Chem. Sci. (2015) 6, 2 1035
a=17.8663(12)Å b=22.1923(15)Å c=22.2835(15)Å
α=90.00° β=90.00° γ=90.00°
CB7_B12H11OH
C42H86B24N28O24
Chemical communications (Cambridge, England) (2018) 54, 17 2098-2101
a=23.0662(16)Å b=28.863(3)Å c=14.2661(10)Å
α=90° β=96.368(7)° γ=90°
CB7_B12Cl12
C168H216B48Cl48N112Na8O80
Chemical communications (Cambridge, England) (2018) 54, 17 2098-2101
a=18.2093(6)Å b=17.9662(5)Å c=27.6070(9)Å
α=90° β=90.792(2)° γ=90°
CB6_B12H12
C121H207B24N77O57
Chemical communications (Cambridge, England) (2018) 54, 17 2098-2101
a=12.6040(6)Å b=14.9311(6)Å c=26.8894(14)Å
α=86.075(4)° β=79.443(4)° γ=87.306(3)°
Iodido[tris(1-methylbenzimidazol-2-ylmethyl)amine]zinc(II) perchlorate dimethylformamide hemisolvate
C27H27IN7Zn,ClO40.5C3H7NO
Acta Crystallographica Section E (2007) 63, 6 m1741-m1741
a=12.743(2)Å b=14.399(3)Å c=14.554(3)Å
α=97.562(2)° β=112.766(2)° γ=114.420(2)°
Diaquabis[N-(2-pyridylmethyl)benzamide-κ^2^O,N]zinc(II) dinitrate
C26H28N4O4Zn2,2(NO3)
Acta Crystallographica Section E (2007) 63, 12 m3068-m3068
a=11.054(2)Å b=8.9058(18)Å c=15.306(3)Å
α=90.00° β=105.037(3)° γ=90.00°
Bis[1,3-bis(benzimidazol-2-yl)-2-oxapropane]copper(II)—–picrate—–\ dimethylformamide (1/2/4)
C32H28CuN8O22,2(C6H2N3O7),4(C3H7NO)
Acta Crystallographica Section E (2008) 64, 12 m1529
a=10.9656(7)Å b=12.6028(12)Å c=13.4100(9)Å
α=65.746(2)° β=88.629(2)° γ=65.187(2)°
Bis[1,3-bis(benzimidazol-2-yl)-2-oxapropane]cobalt(II) dipicrate acetonitrile trisolvate
C32H28CoN8O2,2(C6H2N3O7),3(C2H3N)
Acta Crystallographica Section E (2009) 65, 8 m851
a=11.4114(3)Å b=9.9303(2)Å c=25.1442(6)Å
α=90.00° β=111.1640(10)° γ=90.00°
(Dimethylformamide-κ<i>O</i>)(2-hydroxybenzoato- κ^2^<i>O</i>^1^,<i>O</i>^1^)[tris(1-methyl-1<i>H</i>-benzimidazol-2- ylmethyl-κ<i>N</i>^3^)amine-κ<i>N</i>]manganese(II) perchlorate dimethylformamide monosolvate
C37H39MnN8O4,ClO4,C3H7NO
Acta Crystallographica Section E (2010) 66, 10 m1252
a=12.3689(13)Å b=12.4809(13)Å c=15.3759(16)Å
α=69.9250(10)° β=87.9260(10)° γ=74.7040(10)°
Bis[2,6-bis(1<i>H</i>-benzimidazol-2-yl)pyridine]nickel(II) dipicrate dimethylformamide disolvate
C38H26N10Ni2,2(C6H2N3O7),2(C3H7NO)
Acta Crystallographica Section E (2010) 66, 8 m967
a=14.2087(3)Å b=26.5215(5)Å c=14.6989(3)Å
α=90.00° β=93.7750(10)° γ=90.00°
C156H108N18O92P2W18Zn9
C156H108N18O92P2W18Zn9
ACS applied materials & interfaces (2018) 10, 16 13462-13469
a=18.834(5)Å b=18.834(5)Å c=15.722(5)Å
α=90.00° β=90.00° γ=120.00°
C156H108Co9N18O92P2W18
C156H108Co9N18O92P2W18
ACS applied materials & interfaces (2018) 10, 16 13462-13469
a=18.7938(11)Å b=18.7938(11)Å c=15.7286(13)Å
α=90.00° β=90.00° γ=120.00°
C38H52BN11NiO42W12
C38H52BN11NiO42W12
Journal of the American Chemical Society (2013) 135, 10186-10189
a=25.266(3)Å b=11.4902(12)Å c=22.880(2)Å
α=90.00° β=90.492(2)° γ=90.00°
C38H52BN11NiO42W12
C38H52BN11NiO42W12
Journal of the American Chemical Society (2013) 135, 10186-10189
a=25.187(4)Å b=11.4826(17)Å c=22.862(4)Å
α=90.00° β=90.373(3)° γ=90.00°
C50H45.5BCl0.5N10Ni2O42W12
C50H45.5BCl0.5N10Ni2O42W12
Journal of the American Chemical Society (2013) 135, 10186-10189
a=13.4140(3)Å b=14.9239(4)Å c=20.0622(5)Å
α=90.00° β=102.665(2)° γ=90.00°